Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Medical device industry • Biologics industry • Pharmaceutical industry • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Key leading countries • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Growing demand of CROs • Increase in studies focusing on pharmaceutical industry • Rising demand of e-clinical trials PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Almac Group • DHL • PAREXEL International • Thermo Fisher Scientific • UPS • Other prominent vendors PART 15: APPENDIX • List of abbreviations Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Validation techniques employed for market sizing 2017 Exhibit 06: Global – Market size and forecast 2017-2022 ($ mn) Exhibit 07: Global – Year-over-year growth 2018-2022 (%) Exhibit 08: Five forces analysis 2017 Exhibit 09: Five forces analysis 2022 Exhibit 10: Bargaining power of buyers Exhibit 11: Bargaining power of suppliers Exhibit 12: Threat of new entrants Exhibit 13: Threat of substitutes Exhibit 14: Threat of rivalry Exhibit 15: Market condition - Five forces 2017-2022 Exhibit 16: Customer landscape Exhibit 17: End-user – Market share 2017-2022 (%) Exhibit 18: Comparison by end-user Exhibit 19: Medical device industry – Market size and forecast 2017-2022 ($ mn) Exhibit 20: Medical device industry – Year-over-year growth 2018-2022 (%) Exhibit 21: Biologics industry – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Biologics industry – Year-over-year growth 2018-2022 (%) Exhibit 23: Pharmaceutical industry – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Pharmaceutical industry – Year-over-year growth 2018-2022 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Global – Market share by geography 2017-2022 (%) Exhibit 27: Regional comparison Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 29: Americas – Year-over-year growth 2018-2022 (%) Exhibit 30: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Medical technology industry including IVD market in Europe in 2014 Exhibit 32: Growth of healthcare application in Europe in 2014 (% CAGR) Exhibit 33: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 35: APAC – Year-over-year growth 2018-2022 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Vendor overview Exhibit 46: Almac Group – Business segments Exhibit 47: Almac Group – Organizational developments Exhibit 48: Almac Group – Geographic focus Exhibit 49: Almac Group – Segment focus Exhibit 50: Almac Group – Key offerings Exhibit 51: Vendor overview Exhibit 52: DHL – Business segments Exhibit 53: DHL – Organizational developments Exhibit 54: DHL – Geographic focus Exhibit 55: DHL – Segment focus Exhibit 56: DHL – Key offerings Exhibit 57: Vendor overview Exhibit 58: PAREXEL International – Business segments Exhibit 59: PAREXEL International – Organizational developments Exhibit 60: PAREXEL International – Geographic focus Exhibit 61: PAREXEL International – Segment focus Exhibit 62: PAREXEL International – Key offerings Exhibit 63: Vendor overview Note: Fisher Clinical service is a part of Biopharma Services Division of Thermo Fisher Scientific and operates as an independent company. In business segments, the business offerings of fisher clinical services are included. Exhibit 64: Thermo Fisher Scientific – Business segments Exhibit 65: Thermo Fisher Scientific – Organizational developments Exhibit 66: Thermo Fisher Scientific – Geographic focus Exhibit 67: Thermo Fisher Scientific – Segment focus Exhibit 68: Thermo Fisher Scientific – Key offerings Exhibit 69: Vendor overview Exhibit 70: UPS – Business segments Exhibit 71: UPS – Organizational developments Exhibit 72: UPS – Geographic focus Exhibit 73: UPS – Segment focus Exhibit 74: UPS – Key offerings

Almac Group DHL PAREXEL International Thermo Fisher Scientific UPS Other prominent vendors